Clinical practice to address tamoxifen nonadherence.

Area of Science:

• Oncology
• Endocrinology
• Behavioral Science

Background:

• Tamoxifen is a vital adjuvant therapy for hormone-receptor-positive breast cancer, offering substantial survival benefits.
• Treatment nonadherence significantly diminishes the effectiveness of tamoxifen, leading to lost benefits for many patients.
• Understanding patient perspectives on disease and treatment is key to improving adherence.

Purpose of the Study:

• To examine tamoxifen nonadherence within the Common-Sense Model of Self-Regulation.
• To identify how patient education and communication influence adherence.
• To propose strategies for clinicians to improve patient adherence and outcomes.

Main Methods:

• Analysis of the Common-Sense Model of Self-Regulation framework.
• Review of current patient education and communication strategies.
• Development of recommendations for clinician-patient communication.

Main Results:

• Current communication often promotes an acute, localized view of cancer, hindering adherence.
• A systemic, non-dichotomous model of cancer and treatment goals of homeostasis is proposed.
• Highlighting tamoxifen's beneficial secondary effects can improve patient motivation.

Conclusions:

• Clinicians should adopt a systemic view of hormone-receptor-positive breast cancer, emphasizing homeostasis and subclinical disease.
• Effective communication, including discussion of tamoxifen's benefits, is essential for adherence.
• Developing individualized action plans with patients fosters adherence and integrates patient values.